Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects

Molecular Neurobiology

Volumn 53, Issue 10, 2016, Pages 6938-6949

  Singh, S ^a,b   Srivastava, A ^a   Kumar, V ^a   Pandey, A ^a   Kumar, D ^a,b   Rajpurohit, C S ^a,b   Khanna, V K ^a,b   Yadav, S ^a,b   Pant, A B ^a,b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

3D organoid culture; Developmental neurotoxicity; Induced pluripotent stem cells; Neurotoxicity; Stem cells

Indexed keywords

BRAIN CELL; BRAIN DEVELOPMENT; CELL ACTIVITY; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CYTOPLASM; DEVELOPMENTAL TOXICITY; HUMAN; HUMAN BRAIN ON CHIP MODEL; HUMAN UMBILICAL CORD BLOOD DERIVED STEM CELL; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; MODEL; NEUROSPHERE; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE; THREE DIMENSIONAL CELL CULTURE; TWO DIMENSIONAL CELL CULTURE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; TOXICITY AND INTOXICATION;

ANIMALS; CELL DIFFERENTIATION; GROWTH AND DEVELOPMENT; HUMANS; MODELS, BIOLOGICAL; NEUROTOXICITY SYNDROMES; SPHEROIDS, CELLULAR; STEM CELLS;

EID: 84949770074     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9615-2     Document Type: Review

References (97)

1. Bosnjak ZJ (2012) Developmental neurotoxicity screening using human embryonic stem cells. Exp Neurol 237(1):207–210
2. Costa LG, Giordano G, Guizzetti M, Vitalone A (2007) Neurotoxicity of pesticides: a brief review. Front Biosci 13:1240–1249
3. Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P (2007) Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ Health Perspect 115(6):924–931
4. Kang K-S, Trosko JE (2011) Stem cells in toxicology: fundamental biology and practical considerations. Toxicol Sci 120(suppl 1):S269–S289
5. Laustriat D, Gide J, Peschanski M (2010) Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem Soc Trans 38(4):1051
6. Betts KS (2010) Growing knowledge: using stem cells to study developmental neurotoxicity. Environ Health Perspect 118(10):A432
7. Szebényi K, Erdei Z, Péntek A, Sebe A, Orbán TI, Sarkadi B, Apáti Á (2011) Human pluripotent stem cells in pharmacological and toxicological screening: new perspectives for personalized medicine. Pers Med 8(3):347–364
8. Sison-Young R, Kia R, Heslop J, Kelly L, Rowe C, Cross M, Kitteringham N, Hanley N, Park B, Goldring C (2011) Human pluripotent stem cells for modeling toxicity. Adv Pharmacol (San Diego, Calif) 63:207–256
9. Stiles J, Jernigan TL (2010) The basics of brain development. Neuropsychol Rev 20(4):327–348
10. Silver J, Schwab ME, Popovich PG (2014) Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia. Cold Spring Harb Perspect Biol 7(3):a020602. doi:10.1101/cshperspect.a020602
11. Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315–1530
12. Lu J, Einhorn S, Venkatarangan L, Miller M, Mann DA, Watkins PB, LeCluyse E (2015) Morphological and functional characterization and assessment of iPSC-derived hepatocytes for in vitro toxicity testing. Toxicol Sci 147(1):39–54
13. Kia R, Sison RL, Heslop J, Kitteringham NR, Hanley N, Mills JS, Park BK, Goldring CE (2013) Stem cell‐derived hepatocytes as a predictive model for drug‐induced liver injury: are we there yet? Br J Clin Pharmacol 75(4):885–896
14. McGivern JV, Ebert AD (2014) Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments. Adv Drug Deliv Rev 69:170–178
15. Mordwinkin NM, Burridge PW, Wu JC (2013) A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J Cardiovasc Transl Res 6(1):22–30
16. Sinnecker D, Laugwitz K-L, Moretti A (2014) Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing. Pharmacol Ther 143(2):246–252
17. Clements M, Millar V, Williams A, Kalinka S (2015) Bridging functional and structural cardiotoxicity assays using human embryonic stem-cell derived cardiomyocytes for a more comprehensive risk assessment. Toxicol Sci 148(1):241–260. doi:10.1093/toxsci/kfv180
18. Khan JM, Lyon AR, Harding SE (2013) The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening. Br J Pharmacol 169(2):304–317
19. Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR (2012) Barriers in the developing brain and neurotoxicology. Neurotoxicology 33(3):586–604
20. Van Thriel C, Westerink RH, Beste C, Bale AS, Lein PJ, Leist M (2012) Translating neurobehavioural endpoints of developmental neurotoxicity tests into < i > in vitro assays and readouts. Neurotoxicology 33(4):911–924
21. Kumar V, Jahan S, Singh S, Khanna V, Pant A (2015) Progress toward the development of in vitro model system for chemical-induced developmental neurotoxicity: potential applicability of stem cells. Arch Toxicol 89(2):265–267
22. De Groot MW, Westerink RH, Dingemans MM (2013) Don’t judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing. Toxicol Sci 132(1):1–7
23. Zimmer B, Kuegler P, Baudis B, Genewsky A, Tanavde V, Koh W, Tan B, Waldmann T, Kadereit S, Leist M (2010) Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ 18(3):383–395
24. Lee H-y, Inselman AL, Kanungo J, Hansen DK (2012) Alternative models in developmental toxicology. Syst Biol Reprod Med 58(1):10–22
25. Liu W, Deng Y, Liu Y, Gong W, Deng W (2013) Stem cell models for drug discovery and toxicology studies. J Biochem Mol Toxicol 27(1):17–27
26. Cananzi M, De Coppi P (2012) CD117+ amniotic fluid stem cells: state of the art and future perspectives. Organogenesis 8(3):77–88
27. Nam H, Lee K-H, Nam D-H, Joo KM (2015) Adult human neural stem cell therapeutics: current developmental status and prospect. World J Stem Cells 7(1):126–136
28. Gorba T, Conti L (2013) Neural stem cells as tools for drug discovery: novel platforms and approaches. Expert Opin Drug Discovery 8(9):1083–1094
29. Bellenchi GC, Volpicelli F, Piscopo V, Perrone‐Capano C, di Porzio U (2013) Adult neural stem cells: an endogenous tool to repair brain injury? J Neurochem 124(2):159–167
30. Canovas-Jorda D, Louisse J, Pistollato F, Zagoura D, Bremer S (2014) Regenerative toxicology: the role of stem cells in the development of chronic toxicities. Expert Opin Drug Metab Toxicol 10(1):39–50
31. Hazeltine LB, Selekman JA, Palecek SP (2013) Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv 31(7):1002–1019
32. Lu D, Chen EY, Lee P, Wang Y-C, Ching W, Markey C, Gulstrom C, Chen L-C, Nguyen T, Chin W-C (2014) Accelerated neuronal differentiation toward motor neuron lineage from human embryonic stem cell line (H9). Tissue engineering part C: methods
33. Thompson LH, Björklund A (2015) Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells. Neurobiol Dis 79:28–40. doi:10.1016/j.nbd.2015.04.003
34. Okolicsanyi RK, Griffiths LR, Haupt LM (2014) Mesenchymal stem cells, neural lineage potential, heparan sulfate proteoglycans and the matrix. Dev Biol 388(1):1–10
35. Ferroni L, Gardin C, Tocco I, Epis R, Casadei A, Vindigni V, Mucci G, Zavan B (2013) Potential for neural differentiation of mesenchymal stem cells. In: Mesenchymal stem cells-basics and clinical application I. Springer, Berlin Heidelberg, pp 89–115
36. Nikoletopoulou V, Tavernarakis N (2012) Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology. Biotechnol J 7(9):1156–1168
37. Prè D, Nestor MW, Sproul AA, Jacob S, Koppensteiner P, Chinchalongporn V, Zimmer M, Yamamoto A, Noggle SA, Arancio O (2014) A time course analysis of the electrophysiological properties of neurons differentiated from human induced pluripotent stem cells (iPSCs). PLoS One 9(7):e103418
38. Kashyap MP, Kumar V, Singh AK, Tripathi VK, Jahan S, Pandey A, Srivastava RK, Khanna VK, Pant AB (2014) Differentiating neurons derived from human umbilical cord blood stem cells work as a test system for developmental neurotoxicity. Mol Neurobiol. 1–17
39. Kashyap M, Singh A, Siddiqui M, Kumar V, Tripathi V, Khanna V, Yadav S, Jain S, Pant A (2010) Caspase cascade regulated mitochondria mediated apoptosis in monocrotophos exposed PC12 cells. Chem Res Toxicol 23(11):1663–1672
40. Kashyap MP, Singh AK, Kumar V, Tripathi VK, Srivastava RK, Agrawal M, Khanna VK, Yadav S, Jain SK, Pant AB (2011) Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s. PLoS One 6(3):e17757
41. Singh A, Kashyap M, Jahan S, Kumar V, Tripathi V, Siddiqui M, Yadav S, Khanna V, Jain S, Das V (2012) Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34+ stem cell derived differentiating neuronal cells. Toxicol Sci 129(2):392–410. doi:10.1093/toxsci/kfs213
42. Singh AK, Kashyap MP, Kumar V, Tripathi VK, Yadav DK, Khan F, Jahan S, Khanna VK, Yadav S, Pant AB (2013) 3-Methylcholanthrene induces neurotoxicity in developing neurons derived from human CD34+ Thy1+ stem cells by activation of aryl hydrocarbon receptor. Neuromolecular Med 15(3):570–592
43. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
44. Alvarado AS, Yamanaka S (2014) Rethinking differentiation: stem cells, regeneration, and plasticity. Cell 157(1):110–119
45. Okano H, Yamanaka S (2014) iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain 7(1):22
46. Pei Y, Peng J, Behl M, Sipes NS, Shockley KR, Rao MS, Tice RR, Zeng X (2015) Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res. doi: 10.1016/j.brainres.2015.07.048
47. Zhao J, W-j J, Sun C, C-z H, Yang X-m, Gao J-g (2013) Induced pluripotent stem cells: origins, applications, and future perspectives. J Zhejiang Univ Sci B 14(12):1059–1069
48. Yamanaka S (2009) A fresh look at iPS cells. Cell 137(1):13–17
49. Takahashi K, Yamanaka S (2013) Induced pluripotent stem cells in medicine and biology. Development 140(12):2457–2461
50. Khurana V, Tardiff DF, Chung CY, Lindquist S (2015) Toward stem cell-based phenotypic screens for neurodegenerative diseases. Nat Rev Neurol 11(6):339–50. doi:10.1038/nrneurol.2015.79
51. Sterneckert JL, Reinhardt P, Schöler HR (2014) Investigating human disease using stem cell models. Nat Rev Genet 15(9):625–639
52. Scott CW, Peters MF, Dragan YP (2013) Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol Lett 219(1):49–58
53. Kumar KK, Aboud AA, Bowman AB (2012) The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 33(3):518–529
54. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035–1041
55. Caiazzo M, Dell’Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G (2011) Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476(7359):224–227
56. Qiang L, Fujita R, Yamashita T, Angulo S, Rhinn H, Rhee D, Doege C, Chau L, Vanti WB, Moreno H (2011) Directed conversion of Alzheimer’s disease patient skin fibroblasts into functional neurons. Cell 146(3):359
57. Son EY, Ichida JK, Wainger BJ, Toma JS, Rafuse VF, Woolf CJ, Eggan K (2011) Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9(3):205–218
58. Shtrichman R, Germanguz I, Eldor JI (2013) Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine. Curr Mol Med 13(5):792–805
59. Shamir ER, Ewald AJ (2014) Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat Rev Mol Cell Biol 15(10):647–664
60. Li X, Valadez AV, Zuo P, Nie Z (2012) Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis 4(12):1509–1525
61. Yamada KM, Cukierman E (2007) Modeling tissue morphogenesis and cancer in 3D. Cell 130(4):601–610
62. Bratt‐Leal AM, Carpenedo RL, McDevitt TC (2009) Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 25(1):43–51
63. Kopanitsa MV, Afinowi NO, Grant SG (2006) Recording long-term potentiation of synaptic transmission by three-dimensional multi-electrode arrays. BMC Neurosci 7(1):61
64. Musick K, Khatami D, Wheeler BC (2009) Three-dimensional micro-electrode array for recording dissociated neuronal cultures. Lab Chip 9(14):2036–2042
65. Wallace K, Strickland JD, Valdivia P, Mundy WR, Shafer TJ (2015) A multiplexed assay for determination of neurotoxicant effects on spontaneous network activity and viability from microelectrode arrays. Neurotoxicology 49:79–85. doi:10.1016/j.neuro.2015.05.007
66. Valdivia P, Martin M, LeFew WR, Ross J, Houck KA, Shafer TJ (2014) Multi-well microelectrode array recordings detect neuroactivity of ToxCast compounds. Neurotoxicology 44:204–217
67. Robinette BL, Harrill JA, Mundy WR, Shafer TJ (2011) In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny. Front Neuroeng 4:1. doi:10.3389/fneng.2011.00001
68. Frimat J-P, Sisnaiske J, Subbiah S, Menne H, Godoy P, Lampen P, Leist M, Franzke J, Hengstler JG, van Thriel C (2010) The network formation assay: a spatially standardized neurite outgrowth analytical display for neurotoxicity screening. Lab Chip 10(6):701–709
69. Moors M, Rockel TD, Abel J, Cline JE, Gassmann K, Schreiber T, Schuwald J, Weinmann N, Fritsche E (2009) Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 117(7):1131–1138
70. Terrasso AP, Pinto C, Serra M, Filipe A, Almeida S, Ferreira AL, Pedroso P, Brito C, Alves PM (2015) Novel scalable 3D cell based model for in vitro neurotoxicity testing: combining human differentiated neurospheres with gene expression and functional endpoints. J Biotechnol 205:82–92
71. Baumann J, Gassmann K, Masjosthusmann S, DeBoer D, Bendt F, Giersiefer S, Fritsche E (2015) Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events. Arch Toxicol. 1–13
72. Sasai Y (2013) Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell 12(5):520–530
73. Bershteyn M, Kriegstein AR (2013) Cerebral organoids in a dish: progress and prospects. Cell 155(1):19–20
74. Eiraku M, Sasai Y (2012) Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat Protoc 7(1):69–79
75. Broccoli V, Giannelli SG, Mazzara PG (2014) Modeling physiological and pathological human neurogenesis in the dish. Front Neurosci 8:183. doi:10.3389/fnins.2014.00183
76. Eiraku M, Sasai Y (2012) Self-formation of layered neural structures in three-dimensional culture of ES cells. Curr Opin Neurobiol 22(5):768–777
77. Hatherell K, Couraud P-O, Romero IA, Weksler B, Pilkington GJ (2011) Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 199(2):223–229
78. Pamies D, Hartung T, Hogberg HT (2014) Biological and medical applications of a brain-on-a-chip. Exp Biol Med 239(9):1096–1107. doi:10.1177/1535370214537738
79. Lancaster MA, Renner M, Martin C-A, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, Jackson AP, Knoblich JA (2013) Cerebral organoids model human brain development and microcephaly. Nature 501(7467):373–379
80. Gjorevski N, Ranga A, Lutolf MP (2014) Bioengineering approaches to guide stem cell-based organogenesis. Development 141(9):1794–1804
81. Hogberg HT, Bressler J, Christian KM, Harris G, Makri G, O’Driscoll C, Pamies D, Smirnova L, Wen Z, Hartung T (2013) Toward a 3D model of human brain development for studying gene/environment interactions. Studies 13:15
82. Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME (2015) Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. PLoS One 10(2):e0118020
83. Hubbard K, Beske P, Lyman M, McNutt P (2015) Functional evaluation of biological neurotoxins in networked cultures of stem cell-derived central nervous system neurons. J Vis Exp 96.doi:10.3791/52361
84. Cao WS, Livesey JC, Halliwell RF (2015) An evaluation of a human stem cell line to identify risk of developmental neurotoxicity with antiepileptic drugs. Toxicol In Vitro 29(3):592–599
85. Bai X, Bosnjak ZJ (2013) Emerging model in anesthetic developmental neurotoxicity: human stem cells. Int J Clin Anesthesiol 1:1002
86. Chang S-H, Lee HJ, Kang B, Yu K-N, Minai-Tehrani A, Lee S, Kim SU, Cho M-H (2013) Methylmercury induces caspase-dependent apoptosis and autophagy in human neural stem cells. J Toxicol Sci 38(6):823–831
87. Meamar R, Dehghani L, Karamali F (2012) Toxicity effects of methamphetamine on embryonic stem cell-derived neuron. J Res Med Sci 17(5):470
88. Li T, Wang W, Pan Y-W, Xu L, Xia Z (2013) A hydroxylated metabolite of flame-retardant PBDE-47 decreases the survival, proliferation, and neuronal differentiation of primary cultured adult neural stem cells and interferes with signaling of ERK5 MAP kinase and neurotrophin 3. Toxicol Sci 134(1):111–124. doi:10.1093/toxsci/kft083
89. Mutsaers HA, Tofighi R (2012) Dexamethasone enhances oxidative stress-induced cell death in murine neural stem cells. Neurotox Res 22(2):127–137
90. Rocha R, Gimeno-Alcaniz J, Martin-Ibanez R, Canals J, Velez D, Devesa V (2011) Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicol Lett 203(3):237–244
91. Dye BR, Hill DR, Ferguson MA, Tsai Y-H, Nagy MS, Dyal R, Wells JM, Mayhew CN, Nattiv R, Klein OD (2015) In vitro generation of human pluripotent stem cell derived lung organoids. eLife 4:e05098
92. Xia Y, Sancho-Martinez I, Nivet E, Esteban CR, Campistol JM, Belmonte JCI (2014) The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor–like cells. Nat Protoc 9(11):2693–2704
93. Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9(10):2329–2340
94. Greggio C, De Franceschi F, Figueiredo-Larsen M, Grapin-Botton A (2014) In vitro pancreas organogenesis from dispersed mouse embryonic progenitors. J Vis Exp 89:e51725–e51725
95. Koehler KR, Hashino E (2014) 3D mouse embryonic stem cell culture for generating inner ear organoids. Nat Protoc 9(6):1229–1244
96. Tieng V, Stoppini L, Villy S, Fathi M, Dubois-Dauphin M, Krause K-H (2014) Engineering of midbrain organoids containing long-lived dopaminergic neurons. Stem Cells Dev 23(13):1535–1547
97. Takebe T, Sekine K, Suzuki Y, Enomura M, Tanaka S, Ueno Y, Zheng Y-W, Taniguchi H (2012) Self-organization of human hepatic organoid by recapitulating organogenesis in vitro. Transplant Proc 4(4):1018–1020, Elsevier